title: Suppressed bone turnover during alendronate therapy for high-turnover osteoporosis.
authors.forename: Reina
authors.initials: R
authors.lastname: Armamento-Villareal
authors.forename: Nicola
authors.initials: N
authors.lastname: Napoli
authors.forename: Vinita
authors.initials: V
authors.lastname: Panwar
authors.forename: Deborah
authors.initials: D
authors.lastname: Novack
mesh_terms: D000328:Adult; D019386:Alendronate / Q000009:adverse effects / Q000494:pharmacology*; D015519:Bone Density / Q000187:drug effects*; D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000494:pharmacology*; D016723:Bone Remodeling / Q000187:drug effects*; D050723:Fractures, Bone / Q000209:etiology; D006801:Humans; D007085:Ilium / Q000473:pathology; D008297:Male; D010024:Osteoporosis / Q000188:drug therapy / Q000473:pathology
chemical_list: D050071:Bone Density Conservation Agents; D019386:Alendronate